ExametazimeHMPAO (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Exametazime drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Exametazime
SUBSTANCE NAME: EXAMETAZIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00


Exametazime HMPAO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionExametazime HMPAO from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-214_dd2d8053-37a4-465d-9086-2bd084c4898c
PRODUCT NDC: 51808-214
APPLICATION NUMBER:

Other EXAMETAZIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationExametazime